Comorbidity is defined as an illness that occurs more frequently in association with a specific
disorder than would be found as a coincidental association in the general population …

Migraine is a common, chronic neurologic disorder that affects 11% of the adult population
in Western countries. In this article, we review the current approaches to the pharmacologic …

Migraine is a chronic, intermittently debilitating neurovascular condition that affects the
physical, mental and social aspects of health-related quality of life. Primary care provider …

Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part
series presents a summary of treatments used to reduce the severity and duration of …

Migraine is a common episodic headache disorder. A comprehensive headache treatment
plan includes acute attack treatment to relieve pain and impairment and long-term …

The pharmacological treatment of migraine can be acute or preventive. Acute treatment
attempts to stop the progression of an attack or relieve pain and functional impairment once …

Refractory migraine (RM) headaches pose important treatment challenges to the patients
who live with them and the clinicians who try to treat them. Defined based on the lack of …

Migraine is a common disabling brain disorder that affects one in seven US citizens
annually. The burden of migraine is substantial, both in economic terms and for individual …

This review explains advances in the treatment of chronic migraine, a common disorder
seen in neurological practice. These new advances in preventive treatment and a better …

Migraine, its pathophysiology, and abortive (acute) pharmacotherapy were described in Part
1 of this two-part series in the July issue of P&T. Part 2 discusses the role of preventative …